Vimarsana
Biggest News Aggregation in the World

Page 19 - Herlev News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Herlev. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Herlev Today - Breaking & Trending Today

Nordic Bioscience and Roche Diagnostics Strengthen Collaboration for Development of Biomarkers for Chronic Diseases - Vimarsana News

Nordic Bioscience and Roche Diagnostics Strengthen Collaboration for Development of Biomarkers for Chronic Diseases

/PRNewswire/ -- Nordic Bioscience, a growing biomarker company, today announced the strengthening of its ongoing collaboration with Roche Diagnostics for the...

Empagliflozin does not improve contractile reserve in heart failure: Data from Empire HF trial - Vimarsana News

Empagliflozin does not improve contractile reserve in heart failure: Data from Empire HF trial

Denmark: The addition of SGLT2 inhibitor empagliflozin to guideline-directed HF therapy for 12 weeks did not improve left ventricular (LV) contractile reserve in patients with heart failure (HF) and...

Post-hoc Analysis Offers Hope for Novel Cholesterol Drug - Vimarsana News

Post-hoc Analysis Offers Hope for Novel Cholesterol Drug

Vupanorsen disappointed on triglyceride and non-HDL cholesterol reduction in TRANSLATE-TIMI 70, but post-hoc data on VLDL and remnant cholesterol point to a role for the class if not the drug, experts say.

Lp(a) Linked to ASCVD and Aortic Stenosis Regardless of CRP Level - Vimarsana News

Lp(a) Linked to ASCVD and Aortic Stenosis Regardless of CRP Level

The study counters other data suggesting high Lp(a) levels were only a problem in patients with systemic inflammation.

Source: tctmd.com
Contrasting Evaxion Biotech A/S (NASDAQ:EVAX) and Valneva (NASDAQ:VALN) - Vimarsana News

Contrasting Evaxion Biotech A/S (NASDAQ:EVAX) and Valneva (NASDAQ:VALN)

Evaxion Biotech A/S (NASDAQ:EVAX – Get Rating) and Valneva (NASDAQ:VALN – Get Rating) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their dividends, institutional ownership, analyst recommendations, profitability, valuation, earnings and risk. Insider & Institutional Ownership 4.7% of Evaxion Biotech A/S […]